Header Logo

Connection

Michael Silverberg to HIV Infections

Back to Details
This is a "connection" page, showing publications Michael Silverberg has written about HIV Infections.
Michael Silverberg
Connection Strength
27.245
HIV Infections
  1. Excess Mortality in Persons with Concurrent HIV and Cancer Diagnoses: A Retrospective Cohort Study. Cancer Epidemiol Biomarkers Prev. 2024 Dec 02; 33(12):1698-1705.
    View in: PubMed
    Score: 0.612
  2. Hypertension control and risk of age-associated dementia in people with HIV infection. AIDS. 2025 Jan 01; 39(1):85-90.
    View in: PubMed
    Score: 0.604
  3. Factors associated with suicidal ideation among people with HIV engaged in care. J Affect Disord. 2024 Aug 01; 358:369-376.
    View in: PubMed
    Score: 0.588
  4. Using Electronic Health Records to Improve HIV Preexposure Prophylaxis Care: A Randomized Trial. J Acquir Immune Defic Syndr. 2024 Apr 01; 95(4):362-369.
    View in: PubMed
    Score: 0.584
  5. Self-reported pain severity and use of cannabis and opioids in persons with HIV in an urban primary care setting in Northern California: A cross-sectional study. Medicine (Baltimore). 2024 Mar 29; 103(13):e37581.
    View in: PubMed
    Score: 0.584
  6. Fracture Risk and Association With TDF Use Among People With HIV in Large Integrated Health Systems. J Acquir Immune Defic Syndr. 2023 12 01; 94(4):341-348.
    View in: PubMed
    Score: 0.571
  7. Variation in Heart Failure Risk by HIV Severity and Sex in People With HIV Infection. J Acquir Immune Defic Syndr. 2022 10 01; 91(2):175-181.
    View in: PubMed
    Score: 0.527
  8. Timing of Antiretroviral Therapy Initiation and Risk of Cancer Among Persons Living With Human Immunodeficiency Virus. Clin Infect Dis. 2021 06 01; 72(11):1900-1909.
    View in: PubMed
    Score: 0.480
  9. Comparison of dementia risk after age 50 between individuals with and without HIV infection. AIDS. 2021 04 01; 35(5):821-828.
    View in: PubMed
    Score: 0.475
  10. The relationship of smoking and unhealthy alcohol use to the HIV care continuum among people with HIV in an integrated health care system. Drug Alcohol Depend. 2021 02 01; 219:108481.
    View in: PubMed
    Score: 0.467
  11. Beyond the HIV Care Continuum and Viral Suppression: Broadening the Scope of Quality Metrics for Total HIV Patient Care. AIDS Patient Care STDS. 2020 11; 34(11):461-469.
    View in: PubMed
    Score: 0.461
  12. Smoking and cessation treatment among persons with and without HIV in a U.S. integrated health system. Drug Alcohol Depend. 2020 08 01; 213:108128.
    View in: PubMed
    Score: 0.449
  13. Changes in Days of Unhealthy Alcohol Use and Antiretroviral Therapy Adherence, HIV RNA Levels, and Condomless Sex: A Secondary Analysis of Clinical Trial Data. AIDS Behav. 2020 Jun; 24(6):1784-1792.
    View in: PubMed
    Score: 0.448
  14. Comparison of Overall and Comorbidity-Free Life Expectancy Between Insured Adults With and Without HIV Infection, 2000-2016. JAMA Netw Open. 2020 06 01; 3(6):e207954.
    View in: PubMed
    Score: 0.448
  15. Effectiveness of 'catch-up' human papillomavirus vaccination to prevent cervical neoplasia in immunosuppressed and non-immunosuppressed women. Vaccine. 2020 06 15; 38(29):4520-4523.
    View in: PubMed
    Score: 0.447
  16. Implementing electronic substance use disorder and depression and anxiety screening and behavioral interventions in primary care clinics serving people with HIV: Protocol for the Promoting Access to Care Engagement (PACE) trial. Contemp Clin Trials. 2019 09; 84:105833.
    View in: PubMed
    Score: 0.424
  17. Colorectal Cancer Screening in People With and Without HIV in an Integrated Health Care Setting. . 2019 07 01; 81(3):284-291.
    View in: PubMed
    Score: 0.420
  18. Interventions to Reduce Unhealthy Alcohol Use among Primary Care Patients with HIV: the Health and Motivation Randomized Clinical Trial. J Gen Intern Med. 2019 10; 34(10):2054-2061.
    View in: PubMed
    Score: 0.419
  19. Human Immunodeficiency Virus (HIV)- and Non-HIV-Associated Immunosuppression and Risk of Cervical Neoplasia. Obstet Gynecol. 2018 01; 131(1):47-55.
    View in: PubMed
    Score: 0.379
  20. Association of Multiple Primary Skin Cancers With Human Immunodeficiency Virus Infection, CD4 Count, and Viral Load. JAMA Dermatol. 2017 09 01; 153(9):892-896.
    View in: PubMed
    Score: 0.370
  21. Invasive Pneumococcal Disease Among HIV-Infected and HIV-Uninfected Adults in a Large Integrated Healthcare System. AIDS Patient Care STDS. 2016 10; 30(10):463-470.
    View in: PubMed
    Score: 0.347
  22. Narrowing the Gap in Life Expectancy Between HIV-Infected and HIV-Uninfected Individuals With Access to Care. J Acquir Immune Defic Syndr. 2016 09 01; 73(1):39-46.
    View in: PubMed
    Score: 0.345
  23. Use of Abacavir and Risk of Cardiovascular Disease Among HIV-Infected Individuals. J Acquir Immune Defic Syndr. 2016 Apr 01; 71(4):413-9.
    View in: PubMed
    Score: 0.336
  24. The HIV Care Cascade Measured Over Time and by Age, Sex, and Race in a Large National Integrated Care System. AIDS Patient Care STDS. 2015 Nov; 29(11):582-90.
    View in: PubMed
    Score: 0.326
  25. Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study. Ann Intern Med. 2015 Oct 06; 163(7):507-18.
    View in: PubMed
    Score: 0.324
  26. Antiretroviral Therapy Adherence and Use of an Electronic Shared Medical Record Among People Living with HIV. AIDS Behav. 2015 Jun; 19 Suppl 2:177-85.
    View in: PubMed
    Score: 0.317
  27. Differences in Response to Antiretroviral Therapy by Sex and Hepatitis C Infection Status. AIDS Patient Care STDS. 2015 Jul; 29(7):370-8.
    View in: PubMed
    Score: 0.316
  28. Survival among HIV-infected and HIV-uninfected individuals with common non-AIDS-defining cancers. Cancer Epidemiol Biomarkers Prev. 2015 Aug; 24(8):1167-73.
    View in: PubMed
    Score: 0.311
  29. Declining relative risk for myocardial infarction among HIV-positive compared with HIV-negative individuals with access to care. Clin Infect Dis. 2015 Apr 15; 60(8):1278-80.
    View in: PubMed
    Score: 0.309
  30. HIV infection and incidence of ischemic stroke. AIDS. 2014 Aug 24; 28(13):1911-9.
    View in: PubMed
    Score: 0.300
  31. Prostate cancer incidence and prostate-specific antigen testing among HIV-positive and HIV-negative men. J Acquir Immune Defic Syndr. 2014 Aug 15; 66(5):495-502.
    View in: PubMed
    Score: 0.300
  32. Immunodeficiency and risk of myocardial infarction among HIV-positive individuals with access to care. J Acquir Immune Defic Syndr. 2014 Feb 01; 65(2):160-6.
    View in: PubMed
    Score: 0.289
  33. Factors contributing to risk for cancer among HIV-infected individuals, and evidence that earlier combination antiretroviral therapy will alter this risk. Curr Opin HIV AIDS. 2014 Jan; 9(1):34-40.
    View in: PubMed
    Score: 0.287
  34. HIV infection status, immunodeficiency, and the incidence of non-melanoma skin cancer. J Natl Cancer Inst. 2013 Mar 06; 105(5):350-60.
    View in: PubMed
    Score: 0.268
  35. The effect of HIV infection, immunodeficiency, and antiretroviral therapy on the risk of hepatic dysfunction. J Acquir Immune Defic Syndr. 2012 Jul 01; 60(3):321-7.
    View in: PubMed
    Score: 0.259
  36. Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America. Clin Infect Dis. 2012 Apr; 54(7):1026-34.
    View in: PubMed
    Score: 0.251
  37. Prescription long-term opioid use in HIV-infected patients. Clin J Pain. 2012 Jan; 28(1):39-46.
    View in: PubMed
    Score: 0.250
  38. HIV infection, immunodeficiency, viral replication, and the risk of cancer. Cancer Epidemiol Biomarkers Prev. 2011 Dec; 20(12):2551-9.
    View in: PubMed
    Score: 0.248
  39. HMG-CoA reductase inhibitors (statins) use and risk of non-Hodgkin lymphoma in HIV-positive persons. AIDS. 2011 Sep 10; 25(14):1771-7.
    View in: PubMed
    Score: 0.245
  40. Clinical implications of the nelfinavir-proton pump inhibitor drug interaction in patients with human immunodeficiency virus. Pharmacotherapy. 2011 Mar; 31(3):253-61.
    View in: PubMed
    Score: 0.236
  41. Survival of non-Hodgkin lymphoma patients with and without HIV infection in the era of combined antiretroviral therapy. AIDS. 2010 Jul 17; 24(11):1765-70.
    View in: PubMed
    Score: 0.226
  42. Syphilis epidemiology and clinical outcomes in HIV-infected and HIV-uninfected patients in Kaiser Permanente Northern California. Sex Transm Dis. 2010 Jan; 37(1):53-8.
    View in: PubMed
    Score: 0.218
  43. New insights into the role of HIV infection on cancer risk. Lancet Oncol. 2009 Dec; 10(12):1133-4.
    View in: PubMed
    Score: 0.216
  44. HIV infection and the risk of cancers with and without a known infectious cause. AIDS. 2009 Nov 13; 23(17):2337-45.
    View in: PubMed
    Score: 0.216
  45. Age and racial/ethnic differences in the prevalence of reported symptoms in human immunodeficiency virus-infected persons on antiretroviral therapy. J Pain Symptom Manage. 2009 Aug; 38(2):197-207.
    View in: PubMed
    Score: 0.206
  46. Response to newly prescribed lipid-lowering therapy in patients with and without HIV infection. Ann Intern Med. 2009 Mar 03; 150(5):301-13.
    View in: PubMed
    Score: 0.205
  47. Do antiretrovirals reduce the risk of non-AIDS-defining malignancies? Curr Opin HIV AIDS. 2009 Jan; 4(1):42-51.
    View in: PubMed
    Score: 0.203
  48. Risk of cancers during interrupted antiretroviral therapy in the SMART study. AIDS. 2007 Sep 12; 21(14):1957-63.
    View in: PubMed
    Score: 0.186
  49. Older age and the response to and tolerability of antiretroviral therapy. Arch Intern Med. 2007 Apr 09; 167(7):684-91.
    View in: PubMed
    Score: 0.180
  50. Effectiveness of highly-active antiretroviral therapy by race/ethnicity. AIDS. 2006 Jul 13; 20(11):1531-8.
    View in: PubMed
    Score: 0.171
  51. The Contribution of Socioeconomic Factors to HIV RNA Suppression in Persons With HIV Engaged in Care in the NA-ACCORD. J Acquir Immune Defic Syndr. 2024 Nov 01; 97(3):232-241.
    View in: PubMed
    Score: 0.152
  52. Prevalence of clinical symptoms associated with highly active antiretroviral therapy in the Women's Interagency HIV Study. Clin Infect Dis. 2004 Sep 01; 39(5):717-24.
    View in: PubMed
    Score: 0.150
  53. Evaluation of mean corpuscular volume among anemic people with HIV in North America following ART initiation. AIDS Res Ther. 2024 Aug 07; 21(1):52.
    View in: PubMed
    Score: 0.150
  54. Life and Disability Insurance for People with or at Risk of HIV: Aligning Policy with Evidence. J Insur Med. 2024 Jul 01; 51(1):25-28.
    View in: PubMed
    Score: 0.149
  55. Cardiovascular Risk Estimation Is Suboptimal in People With HIV. J Am Heart Assoc. 2024 May 21; 13(10):e029228.
    View in: PubMed
    Score: 0.147
  56. Care interruptions and mortality among adults in Europe and North America. AIDS. 2024 Aug 01; 38(10):1533-1542.
    View in: PubMed
    Score: 0.147
  57. The forecasted prevalence of comorbidities and multimorbidity in people with HIV in the United States through the year 2030: A modeling study. PLoS Med. 2024 Jan; 21(1):e1004325.
    View in: PubMed
    Score: 0.144
  58. Racial, ethnic, and age disparities in the association of mental health symptoms and polysubstance use among persons in HIV care. PLoS One. 2023; 18(11):e0294483.
    View in: PubMed
    Score: 0.143
  59. Hepatitis B care cascade among people with HIV/HBV coinfection in the North American AIDS Cohort Collaboration on Research and Design, 2012-2016. PLoS One. 2023; 18(9):e0290889.
    View in: PubMed
    Score: 0.140
  60. Contribution of alcohol use in HIV/hepatitis C virus co-infection to all-cause and cause-specific mortality: A collaboration of cohort studies. J Viral Hepat. 2023 09; 30(9):775-786.
    View in: PubMed
    Score: 0.138
  61. Mental health and substance use screening in HIV primary care before and during the early COVID-19 pandemic. BMC Health Serv Res. 2023 May 16; 23(1):494.
    View in: PubMed
    Score: 0.137
  62. Association of Race and Ethnicity With Initial Prescription of Antiretroviral Therapy Among People With HIV in the US. JAMA. 2023 01 03; 329(1):52-62.
    View in: PubMed
    Score: 0.134
  63. Statins Utilization in Adults With HIV: The Treatment Gap and Predictors of Statin Initiation. J Acquir Immune Defic Syndr. 2022 12 15; 91(5):469-478.
    View in: PubMed
    Score: 0.134
  64. The prevalence of mental health disorders in people with HIV and the effects on the HIV care continuum. AIDS. 2023 02 01; 37(2):259-269.
    View in: PubMed
    Score: 0.133
  65. The changing prevalence of anemia and risk factors in people with HIV in North America who have initiated ART, 2007-2017. AIDS. 2023 02 01; 37(2):287-298.
    View in: PubMed
    Score: 0.133
  66. Analysis of Severe Illness After Postvaccination COVID-19 Breakthrough Among Adults With and Without HIV in the US. JAMA Netw Open. 2022 10 03; 5(10):e2236397.
    View in: PubMed
    Score: 0.132
  67. Evaluating the Cardiovascular Risk in an Aging Population of People With HIV: The Impact of Hepatitis C Virus Coinfection. J Am Heart Assoc. 2022 10 04; 11(19):e026473.
    View in: PubMed
    Score: 0.131
  68. Sexually Transmitted Infection Screening in Key Populations of Persons Living with HIV. AIDS Behav. 2023 Jan; 27(1):96-105.
    View in: PubMed
    Score: 0.130
  69. The impact of HIV infection and immunodeficiency on human papillomavirus type 6 or 11 infection and on genital warts. Sex Transm Dis. 2002 Aug; 29(8):427-35.
    View in: PubMed
    Score: 0.130
  70. Longitudinal HIV care outcomes by gender identity in the United States. AIDS. 2022 11 01; 36(13):1841-1849.
    View in: PubMed
    Score: 0.130
  71. Associations of modern initial antiretroviral drug regimens with all-cause mortality in adults with HIV in Europe and North America: a cohort study. Lancet HIV. 2022 06; 9(6):e404-e413.
    View in: PubMed
    Score: 0.129
  72. Analysis of Postvaccination Breakthrough COVID-19 Infections Among Adults With HIV in the United States. JAMA Netw Open. 2022 06 01; 5(6):e2215934.
    View in: PubMed
    Score: 0.129
  73. Development and Validation of a Model for Prediction of End-Stage Liver Disease in People With HIV. J Acquir Immune Defic Syndr. 2022 04 01; 89(4):396-404.
    View in: PubMed
    Score: 0.127
  74. Observed CD4 counts at entry into HIV care and at antiretroviral therapy prescription by age in the USA, 2004-18: a cohort study. Lancet HIV. 2022 03; 9 Suppl 1:S2.
    View in: PubMed
    Score: 0.126
  75. Do contemporary antiretrovirals increase the risk of end-stage liver disease? Signals from patients starting therapy in the North American AIDS Cohort Collaboration on Research and Design. Pharmacoepidemiol Drug Saf. 2022 02; 31(2):214-224.
    View in: PubMed
    Score: 0.124
  76. Treatment for alcohol use disorder among persons with and without HIV in a clinical care setting in the United States. Drug Alcohol Depend. 2021 12 01; 229(Pt A):109110.
    View in: PubMed
    Score: 0.123
  77. Racial, ethnic, and gender disparities in hospitalizations among persons with HIV in the United States and Canada, 2005-2015. AIDS. 2021 07 01; 35(8):1229-1239.
    View in: PubMed
    Score: 0.121
  78. Secular Trends in Breast Cancer Risk Among Women With HIV Initiating ART in North America. J Acquir Immune Defic Syndr. 2021 05 01; 87(1):663-670.
    View in: PubMed
    Score: 0.119
  79. Trends in Hepatocellular Carcinoma Incidence and Risk Among Persons With HIV in the US and Canada, 1996-2015. JAMA Netw Open. 2021 02 01; 4(2):e2037512.
    View in: PubMed
    Score: 0.117
  80. HIV Stigma and Its Associations with Longitudinal Health Outcomes Among Persons Living with HIV with a History of Unhealthy Alcohol Use. AIDS Behav. 2021 Jan; 25(1):215-224.
    View in: PubMed
    Score: 0.117
  81. Early Adopters of Event-driven Human Immunodeficiency Virus Pre-exposure Prophylaxis in a Large Healthcare System in San Francisco. Clin Infect Dis. 2020 12 17; 71(10):2710-2712.
    View in: PubMed
    Score: 0.116
  82. Health care utilization and HIV clinical outcomes among newly enrolled patients following Affordable Care Act implementation in a California integrated health system: a longitudinal study. BMC Health Serv Res. 2020 Nov 11; 20(1):1030.
    View in: PubMed
    Score: 0.116
  83. Weight gain among treatment-naïve persons with HIV starting integrase inhibitors compared to non-nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada. J Int AIDS Soc. 2020 04; 23(4):e25484.
    View in: PubMed
    Score: 0.111
  84. Association of Immunosuppression and Human Immunodeficiency Virus (HIV) Viremia With Anal Cancer Risk in Persons Living With HIV in the United States and Canada. Clin Infect Dis. 2020 03 03; 70(6):1176-1185.
    View in: PubMed
    Score: 0.110
  85. Characterizing the Human Immunodeficiency Virus Care Continuum Among Transgender Women and Cisgender Women and Men in Clinical Care: A Retrospective Time-series Analysis. Clin Infect Dis. 2020 03 03; 70(6):1131-1138.
    View in: PubMed
    Score: 0.110
  86. Life-Expectancy Disparities Among Adults With HIV in the United States and Canada: The Impact of a Reduction in Drug- and Alcohol-Related Deaths Using the Lives Saved Simulation Model. Am J Epidemiol. 2019 12 31; 188(12):2097-2109.
    View in: PubMed
    Score: 0.109
  87. Determinants of Liver Complications Among HIV/Hepatitis B Virus-Coinfected Patients. J Acquir Immune Defic Syndr. 2019 09 01; 82(1):71-80.
    View in: PubMed
    Score: 0.106
  88. Alcohol and drug use, partner PrEP use and STI prevalence among people with HIV. Sex Transm Infect. 2020 05; 96(3):184-188.
    View in: PubMed
    Score: 0.106
  89. Use of electronic health record data and machine learning to identify candidates for HIV pre-exposure prophylaxis: a modelling study. Lancet HIV. 2019 10; 6(10):e688-e695.
    View in: PubMed
    Score: 0.105
  90. Cervical cancer risk in women living with HIV across four continents: A multicohort study. Int J Cancer. 2020 02 01; 146(3):601-609.
    View in: PubMed
    Score: 0.105
  91. Hepatitis C treatment uptake and response among human immunodeficiency virus/hepatitis C virus-coinfected patients in a large integrated healthcare system. Int J STD AIDS. 2019 06; 30(7):689-695.
    View in: PubMed
    Score: 0.104
  92. Association of raltegravir use with long-term health outcomes in HIV-infected patients: an observational post-licensure safety study in a large integrated healthcare system. HIV Clin Trials. 2018 10; 19(5):177-187.
    View in: PubMed
    Score: 0.100
  93. The extent of B-cell activation and dysfunction preceding lymphoma development in HIV-positive people. HIV Med. 2018 02; 19(2):90-101.
    View in: PubMed
    Score: 0.093
  94. A Flow-Based Model of the HIV Care Continuum in the United States. J Acquir Immune Defic Syndr. 2017 08 15; 75(5):548-553.
    View in: PubMed
    Score: 0.092
  95. Increased Risk of Myocardial Infarction in HIV-Infected Individuals in North America Compared With the General Population. J Acquir Immune Defic Syndr. 2017 08 15; 75(5):568-576.
    View in: PubMed
    Score: 0.092
  96. Cancer-Attributable Mortality Among People With Treated Human Immunodeficiency Virus Infection in North America. Clin Infect Dis. 2017 Aug 15; 65(4):636-643.
    View in: PubMed
    Score: 0.092
  97. Association of CD4+ T-cell Count, HIV-1 RNA Viral Load, and Antiretroviral Therapy With Kaposi Sarcoma Risk Among HIV-infected Persons in the United States and Canada. J Acquir Immune Defic Syndr. 2017 08 01; 75(4):382-390.
    View in: PubMed
    Score: 0.092
  98. Prevalence of Drug-Resistant Minority Variants in Untreated HIV-1-Infected Individuals With and Those Without Transmitted Drug Resistance Detected by Sanger Sequencing. J Infect Dis. 2017 08 01; 216(3):387-391.
    View in: PubMed
    Score: 0.092
  99. Novel tumor markers provide improved prediction of survival after diagnosis of human immunodeficiency virus (HIV)-related diffuse large B-cell lymphoma. Leuk Lymphoma. 2018 02; 59(2):321-329.
    View in: PubMed
    Score: 0.091
  100. Risk of End-Stage Renal Disease in HIV-Positive Potential Live Kidney Donors. Am J Transplant. 2017 Jul; 17(7):1823-1832.
    View in: PubMed
    Score: 0.091
  101. HIV Infection, Immunosuppression, and Age at Diagnosis of Non-AIDS-Defining Cancers. Clin Infect Dis. 2017 02 15; 64(4):468-475.
    View in: PubMed
    Score: 0.089
  102. First Occurrence of Diabetes, Chronic Kidney Disease, and Hypertension Among North American HIV-Infected Adults, 2000-2013. Clin Infect Dis. 2017 02 15; 64(4):459-467.
    View in: PubMed
    Score: 0.089
  103. Implementation and Operational Research: Affordable Care Act Implementation in a California Health Care System Leads to Growth in HIV-Positive Patient Enrollment and Changes in Patient Characteristics. J Acquir Immune Defic Syndr. 2016 Dec 15; 73(5):e76-e82.
    View in: PubMed
    Score: 0.088
  104. Preexposure Prophylaxis for HIV Prevention in a Large Integrated Health Care System: Adherence, Renal Safety, and Discontinuation. J Acquir Immune Defic Syndr. 2016 Dec 15; 73(5):540-546.
    View in: PubMed
    Score: 0.088
  105. Racial and Ethnic Differences in Substance Use Diagnoses, Comorbid Psychiatric Disorders, and Treatment Initiation among HIV-Positive and HIV-Negative Women in an Integrated Health Plan. J Psychoactive Drugs. 2016 Nov-Dec; 48(5):377-383.
    View in: PubMed
    Score: 0.087
  106. Higher Time-Updated Body Mass Index: Association With Improved CD4+ Cell Recovery on HIV Treatment. J Acquir Immune Defic Syndr. 2016 10 01; 73(2):197-204.
    View in: PubMed
    Score: 0.087
  107. Risk of End-Stage Liver Disease in HIV-Viral Hepatitis Coinfected Persons in North America From the Early to Modern Antiretroviral Therapy Eras. Clin Infect Dis. 2016 11 01; 63(9):1160-1167.
    View in: PubMed
    Score: 0.086
  108. Response to Therapy in Antiretroviral Therapy-Naive Patients With Isolated Nonnucleoside Reverse Transcriptase Inhibitor-Associated Transmitted Drug Resistance. J Acquir Immune Defic Syndr. 2016 06 01; 72(2):171-6.
    View in: PubMed
    Score: 0.085
  109. Demographic, Insurance, and Health Characteristics of Newly Enrolled HIV-Positive Patients After Implementation of the Affordable Care Act in California. Am J Public Health. 2016 07; 106(7):1211-3.
    View in: PubMed
    Score: 0.084
  110. A picture is worth a thousand words: maps of HIV indicators to inform research, programs, and policy from NA-ACCORD and CCASAnet clinical cohorts. J Int AIDS Soc. 2016; 19(1):20707.
    View in: PubMed
    Score: 0.084
  111. Prevalence of non-HIV cancer risk factors in persons living with HIV/AIDS: a meta-analysis. AIDS. 2016 Jan; 30(2):273-91.
    View in: PubMed
    Score: 0.082
  112. Laboratory Measures as Proxies for Primary Care Encounters: Implications for Quantifying Clinical Retention Among HIV-Infected Adults in North America. Am J Epidemiol. 2015 Dec 01; 182(11):952-60.
    View in: PubMed
    Score: 0.082
  113. Stromal immune infiltration in HIV-related diffuse large B-cell lymphoma is associated with HIV disease history and patient survival. AIDS. 2015 Sep 24; 29(15):1943-51.
    View in: PubMed
    Score: 0.081
  114. Rising Obesity Prevalence and Weight Gain Among Adults Starting Antiretroviral Therapy in the United States and Canada. AIDS Res Hum Retroviruses. 2016 Jan; 32(1):50-8.
    View in: PubMed
    Score: 0.081
  115. Body mass index and early CD4 T-cell recovery among adults initiating antiretroviral therapy in North America, 1998-2010. HIV Med. 2015 Oct; 16(9):572-7.
    View in: PubMed
    Score: 0.079
  116. Impact of age on retention in care and viral suppression. J Acquir Immune Defic Syndr. 2015 Apr 01; 68(4):413-9.
    View in: PubMed
    Score: 0.078
  117. A comparative study of molecular characteristics of diffuse large B-cell lymphoma from patients with and without human immunodeficiency virus infection. Clin Cancer Res. 2015 Mar 15; 21(6):1429-37.
    View in: PubMed
    Score: 0.077
  118. End-stage renal disease among HIV-infected adults in North America. Clin Infect Dis. 2015 Mar 15; 60(6):941-9.
    View in: PubMed
    Score: 0.076
  119. Strong agreement of nationally recommended retention measures from the Institute of Medicine and Department of Health and Human Services. PLoS One. 2014; 9(11):e111772.
    View in: PubMed
    Score: 0.076
  120. Incidence and risk factors of HPV-related and HPV-unrelated Head and Neck Squamous Cell Carcinoma in HIV-infected individuals. Oral Oncol. 2014 Dec; 50(12):1169-76.
    View in: PubMed
    Score: 0.076
  121. Disparities in the quality of HIV care when using US Department of Health and Human Services indicators. Clin Infect Dis. 2014 Apr; 58(8):1185-9.
    View in: PubMed
    Score: 0.072
  122. Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS One. 2013; 8(12):e81355.
    View in: PubMed
    Score: 0.072
  123. Hepatitis C viremia and the risk of chronic kidney disease in HIV-infected individuals. J Infect Dis. 2013 Oct 15; 208(8):1240-9.
    View in: PubMed
    Score: 0.070
  124. Missed office visits and risk of mortality among HIV-infected subjects in a large healthcare system in the United States. AIDS Patient Care STDS. 2013 Aug; 27(8):442-9.
    View in: PubMed
    Score: 0.070
  125. Predicting risk of cancer during HIV infection: the role of inflammatory and coagulation biomarkers. AIDS. 2013 Jun 01; 27(9):1433-41.
    View in: PubMed
    Score: 0.069
  126. Invasive cervical cancer risk among HIV-infected women: a North American multicohort collaboration prospective study. J Acquir Immune Defic Syndr. 2013 Apr 01; 62(4):405-13.
    View in: PubMed
    Score: 0.068
  127. Use of web-based shared medical records among patients with HIV. Am J Manag Care. 2013 Apr 01; 19(4):e114-24.
    View in: PubMed
    Score: 0.068
  128. Retention among North American HIV-infected persons in clinical care, 2000-2008. J Acquir Immune Defic Syndr. 2013 Mar 01; 62(3):356-62.
    View in: PubMed
    Score: 0.068
  129. Trends in annual incidence of methicillin-resistant Staphylococcus aureus (MRSA) infection in HIV-infected and HIV-uninfected patients. Epidemiol Infect. 2013 Nov; 141(11):2392-402.
    View in: PubMed
    Score: 0.068
  130. Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009. Clin Infect Dis. 2013 Apr; 56(8):1174-82.
    View in: PubMed
    Score: 0.067
  131. HIV infection, aging, and immune function: implications for cancer risk and prevention. Curr Opin Oncol. 2012 Sep; 24(5):506-16.
    View in: PubMed
    Score: 0.065
  132. Determination of optimized multidisciplinary care team for maximal antiretroviral therapy adherence. J Acquir Immune Defic Syndr. 2012 Jun 01; 60(2):183-90.
    View in: PubMed
    Score: 0.064
  133. Risk factors for short-term virologic outcomes among HIV-infected patients undergoing regimen switch of combination antiretroviral therapy. AIDS Res Hum Retroviruses. 2012 Dec; 28(12):1630-6.
    View in: PubMed
    Score: 0.064
  134. Risk factors for tuberculosis after highly active antiretroviral therapy initiation in the United States and Canada: implications for tuberculosis screening. J Infect Dis. 2011 Sep 15; 204(6):893-901.
    View in: PubMed
    Score: 0.061
  135. Cancer screening in patients infected with HIV. Curr HIV/AIDS Rep. 2011 Sep; 8(3):142-52.
    View in: PubMed
    Score: 0.061
  136. Missing data on the estimation of the prevalence of accumulated human immunodeficiency virus drug resistance in patients treated with antiretroviral drugs in north america. Am J Epidemiol. 2011 Sep 15; 174(6):727-35.
    View in: PubMed
    Score: 0.061
  137. HIV quality performance measures in a large integrated health care system. AIDS Patient Care STDS. 2011 Jan; 25(1):21-8.
    View in: PubMed
    Score: 0.058
  138. Virologic and immunologic response to HAART, by age and regimen class. AIDS. 2010 Oct 23; 24(16):2469-79.
    View in: PubMed
    Score: 0.058
  139. Late presentation for human immunodeficiency virus care in the United States and Canada. Clin Infect Dis. 2010 Jun 01; 50(11):1512-20.
    View in: PubMed
    Score: 0.056
  140. Impact of tenofovir on renal function in HIV-infected, antiretroviral-naive patients. J Acquir Immune Defic Syndr. 2010 Jan; 53(1):62-9.
    View in: PubMed
    Score: 0.054
  141. Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America. Clin Infect Dis. 2009 Nov 15; 49(10):1582-90.
    View in: PubMed
    Score: 0.054
  142. Increased rates of appendicitis in HIV-infected men: 1991-2005. J Acquir Immune Defic Syndr. 2009 Sep 01; 52(1):139-40.
    View in: PubMed
    Score: 0.053
  143. Race/ethnicity and risk of AIDS and death among HIV-infected patients with access to care. J Gen Intern Med. 2009 Sep; 24(9):1065-72.
    View in: PubMed
    Score: 0.053
  144. Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med. 2009 Apr 30; 360(18):1815-26.
    View in: PubMed
    Score: 0.052
  145. Efficacy and safety of ritonavir-boosted and unboosted atazanavir among antiretroviral-naïve patients. HIV Clin Trials. 2008 Nov-Dec; 9(6):367-74.
    View in: PubMed
    Score: 0.050
  146. Influence of prior antiretroviral experience on adherence and responses to new highly active antiretroviral therapy regimens. AIDS Patient Care STDS. 2008 Apr; 22(4):301-12.
    View in: PubMed
    Score: 0.048
  147. Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients. J Acquir Immune Defic Syndr. 2008 Mar 01; 47(3):384-90.
    View in: PubMed
    Score: 0.048
  148. Effect of clinical pharmacists on utilization of and clinical response to antiretroviral therapy. J Acquir Immune Defic Syndr. 2007 Apr 15; 44(5):531-9.
    View in: PubMed
    Score: 0.045
  149. Serological detection of human papillomavirus type 16 infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women. Clin Vaccine Immunol. 2006 Apr; 13(4):511-9.
    View in: PubMed
    Score: 0.042
  150. How condom use, number of receptive anal intercourse partners and history of external genital warts predict risk for external anal warts. Int J STD AIDS. 2005 Mar; 16(3):203-11.
    View in: PubMed
    Score: 0.039
  151. Effect of antiretroviral therapy on the incidence of genital warts and vulvar neoplasia among women with the human immunodeficiency virus. Am J Obstet Gynecol. 2004 May; 190(5):1241-8.
    View in: PubMed
    Score: 0.037
  152. Discontinuation of potent antiretroviral therapy: predictive value of and impact on CD4 cell counts and HIV RNA levels. AIDS. 2001 Nov 09; 15(16):2101-8.
    View in: PubMed
    Score: 0.031
  153. Disparities in Uptake of HIV Preexposure Prophylaxis in a Large Integrated Health Care System. Am J Public Health. 2016 10; 106(10):e2-3.
    View in: PubMed
    Score: 0.022
  154. Smoking enhances risk for new external genital warts in men. Int J Environ Res Public Health. 2009 03; 6(3):1215-34.
    View in: PubMed
    Score: 0.013
  155. Prospective study of attitudinal and relationship predictors of sexual risk in the multicenter AIDS cohort study. AIDS Behav. 2008 Jan; 12(1):127-38.
    View in: PubMed
    Score: 0.011

© 2024 Kaiser Permanente